Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
name
SciSparc
SPRC.US
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form.
4.845 T
SPRC.USMarket value -Rank by Market Cap -/-

Financial Score

13/06/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking166/196
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-196.55%E
    • Profit Margin-1422.78%E
    • Gross Margin73.71%A
  • Growth ScoreE
    • Revenue YoY-34.46%E
    • Net Profit YoY-93.81%E
    • Total Assets YoY-26.34%E
    • Net Assets YoY-42.42%E
  • Cash ScoreD
    • Cash Flow Margin33.97%D
    • OCF YoY-34.46%E
  • Operating ScoreE
    • Turnover0.1E
  • Debt ScoreB
    • Gearing Ratio32.47%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --